Literature DB >> 903325

Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administration.

J M Dickinson, D A Mitchison, S K Lee, Y Y Ong, M G O'Mahoney, D J Girling, A J Nunn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 903325     DOI： 10.1093/jac/3.5.445

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.

Authors:  Tawanda Gumbo; Arnold Louie; Mark R Deziel; Weiguo Liu; Linda M Parsons; Max Salfinger; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

2.  Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins.

Authors:  G D Gray; C W Smith; J C Hollers; D E Chenoweth; V D Fiegel; R D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Rifampicin induced shock during re-exposure for treatment of latent tuberculosis.

Authors:  Christopher Francis Harlow; Jamilah Meghji; Laura Martin; Timothy Harris; Onn Min Kon
Journal:  BMJ Case Rep       Date:  2020-02-02

4.  Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI.

Authors:  Meng-Rui Lee; Hung-Ling Huang; Shu-Wen Lin; Meng-Hsuan Cheng; Ya-Ting Lin; So-Yi Chang; Bo-Shiun Yan; Ching-Hua Kuo; Po-Liang Lu; Jann-Yuan Wang; Inn-Wen Chong
Journal:  J Clin Med       Date:  2019-06-06       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.